Activity of and Resistance to Moxifloxacin in Staphylococcus aureus
Moxifloxacin has enhanced potency against Staphylococcus aureus, lower propensity to select for resistant mutants, and higher bactericidal activity against highly resistant strains than ciprofloxacin. Despite similar activity against purified S. aureus topoisomerase IV and DNA gyrase, it selects for...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
2003
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC152517/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12654680/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.4.1410-1415.2003 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
